Inhalation

INH1021

Issue link: https://www.e-digitaleditions.com/i/1417310

Contents of this Issue

Navigation

Page 32 of 37

New initiative to bring patient and family voice to children's asthma drug R&D WASHINGTON, DC—Globe Newswire reported that four nonprofit organizations are collaborating on a new initia- tive named "Little Airways, Big Voices." The program is sup- ported by the Allergy & Asthma Network, American Lung Asso- ciation, American Partnership for Eosinophilic Disorders, and the Asthma and Allergy Foundation of America. All information gath- ered from an initial open forum, a survey and written comments will be analyzed and summarized in a Voice of the Patient report to be released in 2022. e col- laborators believe the report will help inform the United States Food and Drug Administration (FDA), researchers, clinicians and drug companies about matters of importance for people living with and managing asthma in children. Inhalation OctOber 2021 31 RespiRatoRy medicine news continued from page 9 Mysuru, India designed to com- pare the respiratory health of adolescent school children in those areas to that in cities that are relatively cleaner with respect to particulate matter air pollu- tion. The children also under- went on-site spirometry. The study, by the Lung Care Foun- dation and Pulmocare Research and Education (PURE) Founda- tion, revealed a high prevalence of symptoms related to asthma and allergy, airway obstruction/asthma and childhood obesity in highly polluted regions. Key findings showed: Delhi's school children have a significantly higher preva- lence of asthma and allergy symp- toms compared to school children in Kottayam and Mysuru; most asthmatic children in Delhi have not been diagnosed with asthma and a vast majority do not receive the right treatment; and air pollu- tion is also an important cause of obesity in children. Hundreds of medical journals call for climate change action WALT HAM , M AS S AC HU- SETTS—Everyday Health reported that more than 200 prominent medical journals—including e New England Journal of Medicine (NEJM), e Lancet and e Brit- ish Medical Journal (BMJ)—have issued an emergency call to action to address climate change. The article "praises governments, finan- cial institutions and businesses that have set net-zero emissions targets and goals aimed to protect at least 30 percent of the world's land and oceans by 2030." However, it urges leaders "to make every effort to keep the global temperature rise below 1.5 degrees Celsius (2.7 degrees Fahrenheit). In particular, the editorial urges governments to intervene to support the redesign of transport systems, cities, pro- duction and distribution of food, markets for financial investments and health systems." Trusted, Reliable Contract Development & Manufacturing renpharm.com R&D Services – Formulation – Scale-up – Stability – 2-100 mL vials – 2-100 mL vials Injectables – Multi-Dose – Unit Dose – Bi-Dose Multi-Dose – Unit Dose – Bi-Dose Nasal Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients' needs.

Articles in this issue

Links on this page

view archives of Inhalation - INH1021